We focus on researching, developing and marketing innovative medicines that have the potential to transform the lives of people around the world with rare and other specialized conditions.Download the PDF
Our purpose is to enable people with life altering conditions to lead better lives.
We aspire to be a leading, global biotech delivering innovative medicines to patients with rare diseases and other specialty conditions.
To guide and motivate us on our journey we seek to achieve product sales of $10 billion by 2020.
To realize our aspiration to become a leading biotech, we will concentrate our efforts on four strategic drivers:
To drive our growth, we have a unified, global business model focused on our strategic drivers. We lead our business through our Executive Committee which, supported by our In-line and Pipeline Committees, ensures we allocate resources and make decisions across the enterprise in the best interests of all our stakeholders – patients, employees, physicians, payers, policy makers and investors.
This streamlined way of working means we can quickly adapt and change our business around the world as we pursue and make the most of opportunities to develop and market innovative treatments that have the potential to transform the lives of people around the world.
Our In-line focus is on marketing products to meet the needs of patients today.
Our Pipeline focus is on the products we are developing to meet the needs of patients tomorrow.
We have a clear and strong patient-focused, performance-based culture which is grounded in our purpose of enabling people with life altering conditions to lead better lives:
We value and invest in our employees to ensure they have the capabilities and support to implement our strategy, achieve our vision and deliver value to all our stakeholders.